Intelligence

M&A Signals

M&A Signals – Deals Announced Through May 13, 2026

By:Christian Banach
onMay 14, 2026

This week’s M&A Signals breaks down standout acquisitions across health, AI, mobile, and sports-tech sectors, with agency takeaways and a complete list of recent deals to watch closely today.

Highlights

Bayer acquired Perfuse Therapeutics — Deal value: $2.45B

Bayer is a pharmaceutical company expanding its ophthalmology pipeline. Perfuse Therapeutics is developing PER-001, a small molecule endothelin receptor antagonist for ophthalmic diseases. The deal is designed to broaden Bayer’s pipeline with Perfuse’s sole pipeline drug and two Phase II programs for eye disorders. It also reinforces Bayer’s commitment to developing therapies for patients with urgen...

Get Unlimited NextBigWin Access

Subscribe to become a NextBigWin Pro member and get access to all our exclusive content. Turn access and intelligence into your next big client win.

Already a member? Login
Subscribe to NextBigWin Pro

Christian Banach

Christian Banach is the founder of NextBigWin and a leader in agency growth and business development, bringing over 20 years of experience. He serves on the 4A’s Expert Network and has helped holdco agencies, such as Energy BBDO, and independents win millions in new business from brands like Disney, Toyota, and Kohl’s.